195 related articles for article (PubMed ID: 21775056)
1. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique.
Li L; Li J; Hao C; Zhang C; Mu K; Wang Y; Zhang T
Cancer Lett; 2011 Nov; 310(1):9-14. PubMed ID: 21775056
[TBL] [Abstract][Full Text] [Related]
2. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the expression and significance of Claudin-5 and CD99 in solid-pseudopapillary neoplasms and neuroendocrine tumors of pancreas].
Zheng HY; Shi YH; Zhang LF; Chen YZ
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):372-5. PubMed ID: 24060069
[TBL] [Abstract][Full Text] [Related]
4. Solid pseudopapillary neoplasm of the pancreas in children: a 15-year experience and the identification of a unique immunohistochemical marker.
Laje P; Bhatti TR; Adzick NS
J Pediatr Surg; 2013 Oct; 48(10):2054-60. PubMed ID: 24094957
[TBL] [Abstract][Full Text] [Related]
5. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
6. [Solid pseudopapillary tumors of the pancreas: clinical and morphological characteristics, specific features of their immunophenotype, and diagnostic problems].
Gurevich LE; Kazantseva IA; Sokolova IN; Korsakova NA; Kuzovleva EI; Chistiakova OA; Aver'ianova IuA; Egorov AV; Britvin TA; Dolzhikov AA; Egorov VI
Arkh Patol; 2014; 76(5):44-54. PubMed ID: 25543408
[TBL] [Abstract][Full Text] [Related]
7. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin-negative acinar cell carcinoma of the pancreas: report of a case showing a solid pseudopapillary growth pattern.
Tajima S; Waki M; Azuma M; Koda K; Ohata A
Med Mol Morphol; 2016 Sep; 49(3):177-81. PubMed ID: 25600280
[TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
[TBL] [Abstract][Full Text] [Related]
11. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas.
Comper F; Antonello D; Beghelli S; Gobbo S; Montagna L; Pederzoli P; Chilosi M; Scarpa A
Am J Surg Pathol; 2009 May; 33(5):768-74. PubMed ID: 19194274
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
[TBL] [Abstract][Full Text] [Related]
14. Nonductal Pancreatic Cancers.
Jun SY; Hong SM
Surg Pathol Clin; 2016 Dec; 9(4):581-593. PubMed ID: 27926361
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
16. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
[TBL] [Abstract][Full Text] [Related]
17. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule.
Chetty R; Serra S
Histopathology; 2008 Feb; 52(3):325-30. PubMed ID: 18269583
[TBL] [Abstract][Full Text] [Related]
18. p120 catenin reduction and cytoplasmic relocalization leads to dysregulation of E-cadherin in solid pseudopapillary tumors of the pancreas.
Chetty R; Jain D; Serra S
Am J Clin Pathol; 2008 Jul; 130(1):71-6. PubMed ID: 18550473
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
20. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas.
Lawlor RT; Daprà V; Girolami I; Pea A; Pilati C; Nottegar A; Piccoli P; Parolini C; Sperandio N; Capelli P; Scarpa A; Luchini C
Virchows Arch; 2019 Jan; 474(1):105-109. PubMed ID: 30132130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
